Market Commentary

Thoughts from Datavant leaders on the evolving health data landscape

Datavant Way: The DNA of Our Distinctive Culture

The greatest companies have distinctive cultures — cultures that attract great people and define how an organization works together to pursue a mission and build a huge business. Some of the greatest companies have written down their cultural playbooks: the Netflix Culture deck (from 2009) and the HP Way (from 1980) were cultural manifestos…

Why the New Interoperability Rules Don’t Yet Mean the Death of the Fax Machine

In a 2018 piece on why American medicine still runs on fax machines, Vox explained why the last decade of US government efforts to automate health data exchange had shown limited results. Earlier this month, new rules from ONC and CMS went into effect focused on making it easier for…

The Fragmentation of Public Health Data

Special thanks to the following individuals for their help writing this article: Surafeal Asgedom, Michael Stebbins, David Shulkin, Niall Brennan, Tom Carton, Andrew von Eschenbach, and Charlie Rothwell.   ***   In the US, there are over 2,000 government health data sets at the federal, state, and local levels, including several…

Further Evidence that COVID-19 Disproportionately Impacts African American, Hispanic, and Low-Income Populations

Over the past several months, studies have indicated that COVID-19 has disproportionately impacted African American and Hispanic populations, as well as socioeconomically disadvantaged groups. A recent Sutter Health study showed that African Americans diagnosed with COVID-19 were 2.7 times more likely to be hospitalized compared to white patients [1]. Using…

How America’s Health Data Infrastructure is Being Used to Fight COVID-19

As part of the tragedy of COVID-19, tens of thousands of new cases are diagnosed in the US each day. In America, the data from these patients are captured across electronic medical records, medical claims, diagnostic tests, pharmacies, and mortality records. Buried in this data are the answers to many…

The Golden Age of Middleware: Why Visa Has Always Been a Great Middleware Company [And Why Buying Plaid Makes Sense]

Author’s Note: I am a huge fan of middleware companies. Datavant is a middleware company connecting health data; my last startup, LiveRamp (now NYSE:RAMP), is the largest marketing middleware company; and I am an investor in a number of middleware companies across industries. The Visa/Plaid combination is a great example of what…

Learning about my genetic mutation (BRCA2), and optimism for the future of health research.

Learning about my genetic mutation (BRCA2), and optimism for the future of health research Last month, I decided to try Color — one of several new personal genetic sequencing tools. Color screens for genetic mutations associated with various cancers and other diseases. As a health data geek, and as a patient with a…

A study showing real world use of “real world data”

Medical research is beginning to make use of “real world data,” the data generated from everyday visits to doctors’ offices by normal patients. A new paper in The Oncologist provides a powerful demonstration of how this data can be applied to real studies. *** The gold standard of medical research has…

Healthcare Predictions for 2019

Slowly but surely, the pace of change in healthcare is starting to accelerate, and 2019 will be a dynamic year for the industry with major regulatory, technological, and business innovation. There will be false hype, breakthroughs, the failure of traditional business models, and plenty of cross-pollination both within healthcare (payers,…